These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

821 related articles for article (PubMed ID: 27015814)

  • 21. Expression and functional heterogeneity of chemokine receptors CXCR4 and CXCR7 in primary patient-derived glioblastoma cells.
    Liu C; Pham K; Luo D; Reynolds BA; Hothi P; Foltz G; Harrison JK
    PLoS One; 2013; 8(3):e59750. PubMed ID: 23555768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
    Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
    Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non-small cell lung cancer.
    Fahham D; Weiss ID; Abraham M; Beider K; Hanna W; Shlomai Z; Eizenberg O; Zamir G; Izhar U; Shapira OM; Peled A; Wald O
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1167-1175.e1. PubMed ID: 22925564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plerixafor Improves Primary Tumor Response and Reduces Metastases in Cervical Cancer Treated with Radio-Chemotherapy.
    Chaudary N; Pintilie M; Jelveh S; Lindsay P; Hill RP; Milosevic M
    Clin Cancer Res; 2017 Mar; 23(5):1242-1249. PubMed ID: 27697997
    [No Abstract]   [Full Text] [Related]  

  • 25. Dual blockade of CXCL12-CXCR4 and PD-1-PD-L1 pathways prolongs survival of ovarian tumor-bearing mice by prevention of immunosuppression in the tumor microenvironment.
    Zeng Y; Li B; Liang Y; Reeves PM; Qu X; Ran C; Liu Q; Callahan MV; Sluder AE; Gelfand JA; Chen H; Poznansky MC
    FASEB J; 2019 May; 33(5):6596-6608. PubMed ID: 30802149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BK K+ channel blockade inhibits radiation-induced migration/brain infiltration of glioblastoma cells.
    Edalat L; Stegen B; Klumpp L; Haehl E; Schilbach K; Lukowski R; Kühnle M; Bernhardt G; Buschauer A; Zips D; Ruth P; Huber SM
    Oncotarget; 2016 Mar; 7(12):14259-78. PubMed ID: 26893360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel CXCR4 Inhibitor CPZ1344 Inhibits the Proliferation, Migration and Angiogenesis of Glioblastoma.
    Luo Z; Wang B; Chen Y; Liu H; Shi L
    Pathol Oncol Res; 2020 Oct; 26(4):2597-2604. PubMed ID: 32632898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy.
    Castro BA; Flanigan P; Jahangiri A; Hoffman D; Chen W; Kuang R; De Lay M; Yagnik G; Wagner JR; Mascharak S; Sidorov M; Shrivastav S; Kohanbash G; Okada H; Aghi MK
    Oncogene; 2017 Jun; 36(26):3749-3759. PubMed ID: 28218903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploiting Microglial Functions for the Treatment of Glioblastoma.
    Dello Russo C; Lisi L; Tentori L; Navarra P; Graziani G; Combs CK
    Curr Cancer Drug Targets; 2017; 17(3):267-281. PubMed ID: 27528361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ABCF1/CXCL12/CXCR4 Enhances Glioblastoma Cell Proliferation, Migration, and Invasion by Activating the PI3K/AKT Signal Pathway.
    Yin X; Xia K; Peng S; Tan B; Huang Y; Wang M; He M
    Dev Neurosci; 2024; 46(3):210-220. PubMed ID: 37757768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.
    Yi L; Zhou X; Li T; Liu P; Hai L; Tong L; Ma H; Tao Z; Xie Y; Zhang C; Yu S; Yang X
    J Exp Clin Cancer Res; 2019 Aug; 38(1):339. PubMed ID: 31382985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined VEGF and CXCR4 antagonism targets the GBM stem cell population and synergistically improves survival in an intracranial mouse model of glioblastoma.
    Barone A; Sengupta R; Warrington NM; Smith E; Wen PY; Brekken RA; Romagnoli B; Douglas G; Chevalier E; Bauer MP; Dembowsky K; Piwnica-Worms D; Rubin JB
    Oncotarget; 2014 Oct; 5(20):9811-22. PubMed ID: 25238146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CXCL12 mediates trophic interactions between endothelial and tumor cells in glioblastoma.
    Rao S; Sengupta R; Choe EJ; Woerner BM; Jackson E; Sun T; Leonard J; Piwnica-Worms D; Rubin JB
    PLoS One; 2012; 7(3):e33005. PubMed ID: 22427929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme.
    Daniele S; La Pietra V; Piccarducci R; Pietrobono D; Cavallini C; D'Amore VM; Cerofolini L; Giuntini S; Russomanno P; Puxeddu M; Nalli M; Pedrini M; Fragai M; Luchinat C; Novellino E; Taliani S; La Regina G; Silvestri R; Martini C; Marinelli L
    Eur J Pharmacol; 2021 Apr; 897():173936. PubMed ID: 33581134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Activation of CXCR4 in human glioma stem cells promotes tumor angiogenesis].
    Ping YF; Yao XH; Bian XW; Chen JH; Zhang R; Yi L; Zhou ZH
    Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):179-83. PubMed ID: 17535685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model.
    Benedetti E; Antonosante A; d'Angelo M; Cristiano L; Galzio R; Destouches D; Florio TM; Dhez AC; Astarita C; Cinque B; Fidoamore A; Rosati F; Cifone MG; Ippoliti R; Giordano A; Courty J; Cimini A
    Oncotarget; 2015 Dec; 6(39):42091-104. PubMed ID: 26540346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in vivo.
    Yang L; Jackson E; Woerner BM; Perry A; Piwnica-Worms D; Rubin JB
    Cancer Res; 2007 Jan; 67(2):651-8. PubMed ID: 17234775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/β-catenin pathway in human colon cancer cells.
    Song ZY; Gao ZH; Chu JH; Han XZ; Qu XJ
    Biomed Pharmacother; 2015 Apr; 71():46-52. PubMed ID: 25960214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regorafenib Reverses Temozolomide-Induced CXCL12/CXCR4 Signaling and Triggers Apoptosis Mechanism in Glioblastoma.
    Chiang IT; Liu YC; Liu HS; Ali AAA; Chou SY; Hsu TI; Hsu FT
    Neurotherapeutics; 2022 Mar; 19(2):616-634. PubMed ID: 35267171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1.
    D'Alterio C; Buoncervello M; Ieranò C; Napolitano M; Portella L; Rea G; Barbieri A; Luciano A; Scognamiglio G; Tatangelo F; Anniciello AM; Monaco M; Cavalcanti E; Maiolino P; Romagnoli G; Arra C; Botti G; Gabriele L; Scala S
    J Exp Clin Cancer Res; 2019 Oct; 38(1):432. PubMed ID: 31661001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.